Publications by authors named "Brayan M Merchan"

Claim this Profile
E
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Alex Bataller, Ana Garrido, Francesca Guijarro, Guadalupe Oñate, Marina Diaz-Beyá, Brayan M Merchan

Blood Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guadecitabine (SGI-110): an investigational drug for the treatment of myelodysplastic syndrome and acute myeloid leukemia.
Georgina S Daher-Reyes, Brayan M Merchan, Karen W L Yee

Expert Opin Investig Drugs· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis